Glucocorticoid-induced hyperglycemia and diabetes: Practical points

Area of Science:

• Endocrinology
• Pharmacology

Background:

• Glucocorticoids are anti-inflammatory drugs with a high incidence of hyperglycemia.
• Hyperglycemia results from reduced insulin secretion and action, impacting glucose metabolism.

Purpose of the Study:

• To outline screening and management strategies for glucocorticoid-induced hyperglycemia.
• To discuss appropriate antidiabetic therapies based on patient history and glycemic control.

Main Methods:

• Assessing patient history and HbA1c for pre-existing diabetes.
• Utilizing capillary glucose measurements for afternoon hyperglycemia screening.
• Evaluating different antidiabetic medication regimens, including insulin and gliclazide.

Main Results:

• Glucocorticoids induce afternoon hyperglycemia, detectable by capillary glucose monitoring.
• Pre-existing diabetes requires careful management, potentially with basal-bolus insulin.
• De novo diabetes may benefit from simpler regimens like morning intermediate-acting insulin or gliclazide.

Conclusions:

• Effective management of glucocorticoid-induced hyperglycemia requires timely screening and individualized treatment.
• Adjusting antidiabetic therapy as glucocorticoid dosage changes is essential.
• Ongoing research aims for safer, hypoglycemia-free alternatives for managing steroid-induced diabetes.